Franklin Resources’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.53M Sell
18,425
-588
-3% -$80.8K ﹤0.01% 1628
2025
Q1
$3.43M Sell
19,013
-165,014
-90% -$29.8M ﹤0.01% 1485
2024
Q4
$28.8M Sell
184,027
-59,733
-25% -$9.36M 0.01% 795
2024
Q3
$43.8M Buy
243,760
+62,178
+34% +$11.2M 0.01% 650
2024
Q2
$33.3M Buy
181,582
+50,117
+38% +$9.2M 0.01% 678
2024
Q1
$23.4M Buy
131,465
+104,919
+395% +$18.7M 0.01% 815
2023
Q4
$3.29M Buy
26,546
+68
+0.3% +$8.44K ﹤0.01% 1232
2023
Q3
$3.07M Buy
26,478
+11,238
+74% +$1.3M ﹤0.01% 1233
2023
Q2
$1.79M Buy
15,240
+10,608
+229% +$1.25M ﹤0.01% 1446
2023
Q1
$371K Hold
4,632
﹤0.01% 1788
2022
Q4
$367K Buy
4,632
+25
+0.5% +$1.98K ﹤0.01% 1788
2022
Q3
$321K Buy
4,607
+1,141
+33% +$79.5K ﹤0.01% 1820
2022
Q2
$228K Sell
3,466
-271
-7% -$17.8K ﹤0.01% 1977
2022
Q1
$249K Buy
+3,737
New +$249K ﹤0.01% 2087
2021
Q4
Sell
-140,004
Closed -$7.31M 2515
2021
Q3
$7.31M Hold
140,004
﹤0.01% 1122
2021
Q2
$9.52M Buy
140,004
+15,000
+12% +$1.02M ﹤0.01% 1013
2021
Q1
$9.63M Buy
+125,004
New +$9.63M ﹤0.01% 979